Literature DB >> 21088745

Emerging Medical Therapies for the Treatment of GERD.

Jan Tack1.   

Abstract

Entities:  

Year:  2010        PMID： 21088745      PMCID： PMC2976861     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease.

Authors:  Guy E Boeckxstaens; Hanneke Beaumont; Veerle Mertens; Hans Denison; Magnus Ruth; John Adler; Debra G Silberg; Daniel Sifrim
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

Review 2.  GABAB receptor agonism as a novel therapeutic modality in the treatment of gastroesophageal reflux disease.

Authors:  Anders Lehmann; Jörgen M Jensen; Guy E Boeckxstaens
Journal:  Adv Pharmacol       Date:  2010

3.  Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease.

Authors:  C Calabrese; E Spisni; G Liguori; G Lazzarini; M C Valerii; A Strillacci; P Gionchetti; U Pagotto; M Campieri; F Rizzello
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

Review 4.  TRP channels in neurogastroenterology: opportunities for therapeutic intervention.

Authors:  Werend Boesmans; Grzegorz Owsianik; Jan Tack; Thomas Voets; Pieter Vanden Berghe
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.

Authors:  Lauren B Gerson; F Jacob Huff; Amine Hila; William K Hirota; Sandra Reilley; Amit Agrawal; Ritu Lal; Wendy Luo; Donald Castell
Journal:  Am J Gastroenterol       Date:  2009-12-29       Impact factor: 10.864

6.  A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease.

Authors:  C Keywood; M Wakefield; J Tack
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059
  6 in total
  1 in total

1.  Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD).

Authors:  Mohammad Abbasinazari; Yunes Panahi; Seyed Alireza Mortazavi; Fanak Fahimi; Ghasem Valizadegan; Reza Mohtashami; Mohammad Amin Pourhoseingholi; Kambiz Shirvani Bakhtiari
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.